Other · developed by Zai Lab Co.
ZL-1503 is a investigational agent studied in healthy volunteers and in participants with moderate to severe atopic dermatitis.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07235384 | Phase 1 | Atopic Dermatitis (AD) | Recruiting | ZLAB |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Atopic Dermatitis (AD)
Updated Nov 1, 2026. Something wrong or missing? Report it on the ZLAB page.
See ZLAB's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
ZLAB catalysts and pipeline →